The acne “cure” so many teens are familiar with is being pulled from the market.
Roche Holding, AG, has taken Accutane off of the US Market following 6 adverse (that means bad for Roche) jury awards of over $33 million for allegations that it caused bowel disease in users. Specifically ulcerative colitis and Chron’s Disease. The most recent check in the loss column was a $12.9 million New Jersey Verdict last fall. Accutane has previously been alleged to cause both birth defects and depression.
Every jury to hear an Accutane case has reached the same determination that Roche failed to properly warn of the risks to patients who were prescribed Accutane. Apparently Roche was aware of a potential bowel disease incidence as early as 1994.
And for you American Judicial System haters, note that Roche claims safety is not the reason for pulling Accutane from the US market, oh and from, 11 other countries, including: France, Denmark, Austria, Germany, Portugal, Norway and Spain. Yeah. Riiiigggghhhhhttt.
~posted by David Marc Schwadron, Esquire